Exploring the effect of clinical case definitions on influenza vaccine effectiveness estimation at primary care level: Results from the end-of-season 2022–23 VEBIS multicentre study in Europe-Reference-Cited by-同舟云学术

Exploring the effect of clinical case definitions on influenza vaccine effectiveness estimation at primary care level: Results from the end-of-season 2022–23 VEBIS multicentre study in Europe

Published:2024-06 Issue:16 Volume:42 Page:3547-3554
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Maurel Marine^ORCID,Mazagatos Clara^ORCID,Goerlitz Luise^ORCID,Oroszi Beatrix^ORCID,Hooiveld Mariette^ORCID,Machado Ausenda^ORCID,Domegan Lisa^ORCID,Ilić Maja^ORCID,Popescu Rodica,Sève Noémie,Martínez-Baz Iván^ORCID,Larrauri Amparo^ORCID,Buda Silke,Túri Gergő^ORCID,Meijer Adam^ORCID,Gomez Verónica^ORCID,O'Donnell Joan,Mlinarić Ivan^ORCID,Timnea Olivia,Diez Ana Ordax,Dürrwald Ralf,Horváth Judit Krisztina,Dijkstra Frederika^ORCID,Rodrigues Ana Paula,McKenna Adele,Filipović Sanja Kurečić,Lazar Mihaela,Kaczmarek Marlena^ORCID,Bacci Sabrina,Kissling Esther^ORCID

Funder

European Centre for Disease Prevention and Control

Publisher

Elsevier BV

Reference31 articles.

1. Interim 2019/20 influenza vaccine effectiveness: six European studies, September 2019 to January 2020;Rose;Eurosurveillance,2020

2. Influenza vaccine effectiveness in the United States during the 2016–2017 season;Flannery;Clin Infect Dis Off Publ Infect Dis Soc Am,2019

3. Interim estimates of 2017–18 seasonal influenza vaccine effectiveness — United States, February 2018;Flannery;Am J Transplant,2018

4. Interim estimates of 2019/20 vaccine effectiveness during early-season co-circulation of influenza A and B viruses, Canada, February 2020;Skowronski;Eurosurveillance,2020

5. Influenza vaccine effectiveness by A(H3N2) phylogenetic subcluster and prior vaccination history: 2016–2017 and 2017–2018 epidemics in Canada;Skowronski;J Infect Dis,2020